Kawasaki Disease with Peripheral and Facial Gangrene: A Case report and review of literature.
Trop Doct
; 52(3): 449-452, 2022 Jul.
Article
in English
| MEDLINE | ID: covidwho-1765280
ABSTRACT
With the onset of the SARS-CoV-2 pandemic, Kawasaki Disease (KD) has come to the fore with its many atypical manifestations. Atypical clinical neurological, ophthalmological, musculoskeletal, gastrointestinal and pulmonary manifestations in a febrile child with raised markers should prompt the clinician to think of Kawasaki disease. Peripheral gangrene is a rare atypical manifestation of KD reported in infancy. We present a three-and-a-half-year-old boy with extensive gangrene all four limbs and face along with purpura fulminans. He was successfully treated with two doses of intravenous immunoglobulin (IVIG) and infliximab, with no residual gangrene. This case highlights that very severe forms of Kawasaki disease require IVIG, pulse steroids as well as infliximab for adequate control and complete resolution of the disease.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Mucocutaneous Lymph Node Syndrome
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Child, preschool
/
Humans
/
Male
Language:
English
Journal:
Trop Doct
Year:
2022
Document Type:
Article
Affiliation country:
00494755221081598
Similar
MEDLINE
...
LILACS
LIS